|
|
Advisors
Aileron's scientific advisors include a powerful set of industry leaders who have the critical expertise across all facets of peptide drug science and technology.
- Elliot Ehrich, M.D.
- Scientific Advisory Board Member
Senior Vice President, Research & Development, and Chief Medical Officer, Alkermes Inc.
- Stephen W. Fesik, Ph.D.
- Scientific Advisory Board Member
Orrin H. Ingram, II Chair in Cancer Research and Professor of Biochemistry, Pharmacology, and Chemistry, Vanderbilt University; Member of the Vanderbilt-Ingram Cancer Center, the Vanderbilt Institute of Chemical Biology, and the Center for Structural Biology. Prior to joining the Vanderbilt faculty in 2009, Dr. Fesik had a 26-year career at Abbott Laboratories where he was a pioneer in the applications of NMR spectroscopy to drug design. He most recently served as divisional vice president of cancer research at Abbott and led a group responsible for several cancer drug discovery programs.
- Robert H. Grubbs, Ph.D.
- Scientific Advisory Board Member
Victor and Elizabeth Atkins Professor of Chemistry, California Institute of Technology, Pasadena, Calif. Dr. Grubbs was awarded the Nobel Prize in Chemistry in 2005 for the development of ruthenium-catalyzed metathesis of olefins, a powerful synthetic method to create carbon-based linkages within a single compound or between two different compounds. This chemistry is widely used by the chemical and pharmaceutical industries in a variety of processes, including Aileron's Stapled Peptide Technology, and enables the discovery of novel drugs having unique properties for the treatment of various diseases.
- Michael Hanley, Ph.D.
- Scientific Advisory Board Member
CEO and Chairman, Celtaxys. Dr. Hanley brings more than 20 years of experience in the life science industry including drug discovery, product development, and production. He was most recently the chief scientific officer for Amylin Pharmaceuticals.
- Victor J. Hruby, Ph.D.
- Scientific Advisor
Regents Professor Emeritus of Chemistry, University of Arizona; Hirschmann Award Winner; Merrifield Award Winner; Arthur C. Cope Scholar Award Winner
- Michael B. Kastan, M.D., Ph.D.
- Scientific Advisory Board Member
Director of the Cancer Center, Director of the Molecular Therapeutics Division and Co-Director of the Molecular Oncology Program, St. Jude Children's Research Hospital
- David G. Nathan, M. D.
- Scientific Advisory Board Member
President Emeritus, Dana-Farber Cancer Institute. Robert A. Stranahan Distinguished Professor of Pediatrics and Professor of Medicine, Harvard Medical School
- Loren D. Walensky, M.D., Ph.D.
- Scientific Advisory Board Member
Assistant Professor of Pediatrics; Medical Director, Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Harvard Medical School
|
